Terazosin Hydrochloride Capsule
Product Images NDC 63629-1414

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Terazosin Hydrochloride (NDC 63629-1414). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lbl636291414

The text is a pharmaceutical label for Terazosin capsules containing 5 mg of Terazosin Hydrochloride. It includes instructions for use, storage conditions, and contact information for the manufacturer. The capsules are intended for dispensing by a pharmacist to patients with a prescription. It is recommended to store the capsules in a tight, light-resistant container at a temperature range of 20°C to 25°C (68°F to 77°F) and to protect them from light and moisture. For full prescribing information, scanning the package insert QR code is suggested.*

FDA Label Image

Chemical Structure (Terazosin Hydrochloride Capsules 1)

FDA Label Image

Terazosin Hydrochloride Capsules 2

FDA Label Image

Terazosin Hydrochloride Capsules 3

FDA Label Image

Terazosin Hydrochloride Capsules 4

This text appears to represent a timeline or graph showing the measurement of an unknown parameter in milliliters per second over a period of time from 0 months to 30 months. The values are given at various intervals such as 0, 3, 6, 12, 15, 18, 21, 24, 27, and 30 months. The specific parameter being measured is not specified in the provided text snippet.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.